Home
/
Emergent BioSolutions Inc. (EBS)
Home
News
General News
General Crypto News
Facebook
Amazon
Apple
Netflix
Google
Insights
Market Performance
About us
About us
Terms and Conditions
Privacy Policy
Contact us
My Account
NVIDIA Unleashes AI Power: Supercomputers, Cybersecurity, and Healthcare Disruption
NVDA
Tesla’s “We, Robot” Event: A Bold Play for the Future
TSLA
Uber's Bold Step Into Driverless Rides: Here's What It Means for the Future of Travel
UBER
GOOGL
GOOG
Nvidia's Wild Ride: Buy, Sell, or Just Hang Tight?
NVDA
MicroStrategy's Big Bitcoin Bet: Risky or Genius?
MSTR
Nike's Latest Results: Struggles Beneath the Swoosh
NKE
Levi Strauss' Bold Gambit: Is the Denim Icon's DTC Shift Enough to Weather the Storm?
LEVI
EBS | Emergent BioSolutions Inc.
1D
5D
1M
3M
1Y
5Y
$
Current Price
$0
Today (USD)
%
Today %
Two Pharma Companies That Will Profit From The MonkeyPox Outbreak
The monkeypox outbreak has affected 780 people since identified on May 13, 2022. Vaccines are key to curtailing the spread of Monekey Pox. Two pharma companies, Geovax Labs Inc. and Emergent Biosolutions, have already benefited from the outbreak.
By Precious Njoku |
2 years ago
EBS
GOVX
Load More